This past month, the U.S. Department of Health and Human Services issued a most welcome clarification regarding the Affordable Care Act. It is hard to overstate the importance of this guidance.
With decisions last month in two high-profile cases in which we participated, and two Lambda Legal cases cued up for possible review next term, never before have we had so much at stake in a short period on the biggest legal stage in the country.
